Plunkett Research Online: Evelo Biosciences Inc

EVELO BIOSCIENCES INC (EVLO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Evelo Biosciences Inc operates as a bio-technology company. It is an immuno-microbiome company, develops immunotherapies for the treatment of cancer, oncology, neuroinflammation, metabolism, autoimmune, and inflammatory diseases. The company develops therapies for the treatment of the gut-body netwo.....



Evelo Biosciences Inc
Ticker: EVLO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 577-0300
Fax:
Address: 620 Memorial Drive
5th Floor
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description

Balkrishan Gill CEO/Director/President
Jonathan Poole CFO/Chief Accounting Officer/Treasurer
See More
Evelo Biosciences Inc operates as a bio-technology company. It is an immuno-microbiome company, develops immunotherapies for the treatment of cancer, oncology, neuroinflammation, metabolism, autoimmune, and inflammatory diseases. The company develops therapies for the treatment of the gut-body netwo.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: